Relationships Between Vasomotor Symptoms and Mood in Midlife Urban Chinese Women: Observations in a Prospective Study

被引:14
|
作者
Tang, Ruiyi [1 ]
Luo, Min [1 ]
Li, Jiayi [1 ]
Peng, Yajing [1 ]
Wang, Yuchen [1 ]
Liu, Bing [1 ]
Liu, Gaifen [1 ,2 ]
Wang, Yaping [1 ]
Lin, Shouqing [1 ]
Chen, Rong [1 ]
机构
[1] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Peking Union Med Coll, Dept Obstet & Gynecol, Beijing 100730, Peoples R China
[2] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurol, Beijing 100070, Peoples R China
来源
基金
中国国家自然科学基金;
关键词
vasomotor symptom; menopause; perimenopause; depression; anxiety; MENOPAUSAL HOT FLASHES; QUALITY-OF-LIFE; DEPRESSIVE SYMPTOMS; HOSPITAL ANXIETY; PSYCHOLOGICAL SYMPTOMS; REPRODUCTIVE HORMONES; POSTMENOPAUSAL WOMEN; LONGITUDINAL CHANGE; HEALTH; TRANSITION;
D O I
10.1210/clinem/dgaa554
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context: During the menopausal transition, there is a greater likelihood of the prevalence of various bothersome symptoms, including vasomotor symptoms (VMS) and mood symptoms. Objective: To investigate the association among bothersome VMS and symptoms of anxiety and depression in Chinese women during perimenopause and early in menopause. Design, Patients, Setting, and Interventions: This study included 430 midlife Chinese women who had experienced natural menopause and were followed up for 10 years. A structured questionnaire was provided annually, comprising the VMS Bother Score (range 1-8) from the Menopause-Specific Quality of Life questionnaire, the Hospital Anxiety and Depression Scale, and other physical and behavioral factors. Results: Among the 430 women evaluated, 78.8% had experienced VMS during long-term follow-up.The overall level of VMS bother score was relatively low (1.92 +/- 1.32). Both anxiety and depressive symptoms were significantly associated with VMS bother. After adjusting for potential covariates, the association between anxiety or depression symptoms and VMS bother remained highly significant. Menopausal stage, body mass index, general health, follicle-stimulating hormone, and estradiol were independent contributors to VMS. In time-lagged (1-year) models, VMS bother scores significantly predicted the risk of symptoms of both anxiety and depression the following year. In contrast, anxiety symptoms, rather than depressive symptoms, could predict VMS bother the following year. Conclusion: The prevalence of VMS in our cohort was higher than has been previously reported; however, the overall level of bother was relatively low. This study demonstrated a strong relationship between VMS bother and mood symptoms in Chinese women progressing from perimenopause through natural menopause.
引用
收藏
页数:12
相关论文
共 50 条
  • [31] Vasomotor menopausal symptoms and cardiovascular disease risk in midlife: A longitudinal study
    Dam, V
    Dobson, A. J.
    Onland-Moret, N. C.
    van der Schouw, Y. T.
    Mishra, G. D.
    MATURITAS, 2020, 133 : 32 - 41
  • [32] Impact of nulliparity, hypertensive disorders of pregnancy, and gestational diabetes on vasomotor symptoms in midlife women
    Cortes, Yamnia, I
    Conant, Rhoda
    Catov, Janet M.
    Matthews, Karen A.
    Crawford, Sybil L.
    Hedderson, Monique M.
    Thurston, Rebecca C.
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2020, 27 (12): : 1363 - 1370
  • [33] Effects of Tryptophan Depletion on Mood, Vasomotor Symptoms and Sleep in Midlife Women on Estrogen Therapy: Double Blind Placebo-Controlled Crossover Trial
    Soares, Claudio N.
    Fedorkow, Donna
    Mahoney, Julie
    Minuzzi, Luciano
    Costescu-Green, Dustin
    Hall, Geoffrey
    Steiner, Meir
    Frey, Benicio
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2017, 24 (12): : 1460 - 1461
  • [34] Hyperandrogenic Symptoms Are a Persistent Suffering in Midlife Women with PCOS; a Prospective Cohort Study in Sweden
    Persson, Sofia
    Ubhayasekera, Kumari A.
    Bergquist, Jonas
    Turkmen, Sahruh
    Poromaa, Inger Sundstroem
    Elenis, Evangelia
    BIOMEDICINES, 2023, 11 (01)
  • [35] Hyperandrogenic symptoms are a persistent suffering in midlife women with PCOS: a prospective cohort study in Sweden
    Persson, Sofia
    Ubhayasekera, Kumari A.
    Bergquist, Jonas
    Turkmen, Sahruh
    Poromaa, Inger Sundstrom
    Elenis, Evangelia
    ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2023, 102 : 62 - 63
  • [36] Reduced work limitation with improvement in mood, sleep and vasomotor symptoms in postmenopausal women
    Bobula, J. D.
    Yu, H.
    Olivier, S.
    VALUE IN HEALTH, 2007, 10 (03) : A5 - A6
  • [37] Self-reported anxiety, depressive, and vasomotor symptoms: a study of perimenopausal women presenting to a specialized midlife assessment center
    Seritan, Andreea L.
    Iosif, Ana-Maria
    Park, Ju Hui
    DeatherageHand, Deborah
    Sweet, Richard L.
    Gold, Ellen B.
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2010, 17 (02): : 410 - 415
  • [38] A selective serotonin receptor agonist for weight loss and management of menopausal vasomotor symptoms in overweight midlife women: a pilot study
    Kapoor, Ekta
    Faubion, Stephanie
    Hurt, Ryan T.
    Fischer, Karen
    Schroeder, Darrell
    Fokken, Shawn
    Croghan, Ivana T.
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2020, 27 (11): : 1228 - 1235
  • [39] Vasomotor symptoms and lipids/lipoproteins in midlife women: Does level of endogenous estradiol matter? The SWAN HDL Ancillary study
    Nasr, Alexis
    Matthews, Karen
    Brooks, Maria
    McConnell, Dan
    Billheimer, Jeff
    Orchard, Trevor
    Rader, Dan
    El Khoudary, Samar R.
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2019, 26 (12): : 1472 - 1472
  • [40] Vasomotor symptoms and carotid artery intima-media thickness among Korean midlife women
    Ryu, Ki-Jin
    Park, Hyuntae
    Park, Jin Seol
    Lee, Yeon Woo
    Kim, Soo Young
    Kim, Hayun
    Lee, Yeon Ju
    Kim, Tak
    MATURITAS, 2022, 159 : 1 - 6